174 related articles for article (PubMed ID: 33413711)
1. Changes in striatal dopamine transporters in bipolar disorder and valproate treatment.
Hsueh YS; Lin CY; Chiu NT; Yang YK; Chen PS; Chang HH
Eur Psychiatry; 2021 Jan; 64(1):e9. PubMed ID: 33413711
[TBL] [Abstract][Full Text] [Related]
2. Higher striatal dopamine transporters in euthymic patients with bipolar disorder: a SPECT study with [Tc] TRODAT-1.
Chang TT; Yeh TL; Chiu NT; Chen PS; Huang HY; Yang YK; Lee IH; Lu RB
Bipolar Disord; 2010 Feb; 12(1):102-6. PubMed ID: 20148872
[TBL] [Abstract][Full Text] [Related]
3. Chronic valproate attenuates some, but not all, facets of mania-like behaviour in mice.
van Enkhuizen J; Geyer MA; Kooistra K; Young JW
Int J Neuropsychopharmacol; 2013 Jun; 16(5):1021-31. PubMed ID: 23164454
[TBL] [Abstract][Full Text] [Related]
4. Striatal Dopamine Transporter Availability is Associated with Sleep Disturbance among Patients with Bipolar I Disorder: A Single-photon Emission Computed Tomography Study Using [
Lu TH; Lin SH; Tseng HH; Yang YK; Chiu NT; Chen PS
Clin Psychopharmacol Neurosci; 2022 Nov; 20(4):768-772. PubMed ID: 36263651
[TBL] [Abstract][Full Text] [Related]
5. The mood stabilizer valproic acid opposes the effects of dopamine on circadian rhythms.
Landgraf D; Joiner WJ; McCarthy MJ; Kiessling S; Barandas R; Young JW; Cermakian N; Welsh DK
Neuropharmacology; 2016 Aug; 107():262-270. PubMed ID: 27033596
[TBL] [Abstract][Full Text] [Related]
6. The relationship between the striatal dopamine transporter and novelty seeking and cognitive flexibility in opioid dependence.
Liang CS; Ho PS; Yen CH; Chen CY; Kuo SC; Huang CC; Yeh YW; Ma KH; Huang SY
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Mar; 74():36-42. PubMed ID: 27940252
[TBL] [Abstract][Full Text] [Related]
7. Higher striatal dopamine transporter density in PTSD: an in vivo SPECT study with [(99m)Tc]TRODAT-1.
Hoexter MQ; Fadel G; Felício AC; Calzavara MB; Batista IR; Reis MA; Shih MC; Pitman RK; Andreoli SB; Mello MF; Mari JJ; Bressan RA
Psychopharmacology (Berl); 2012 Nov; 224(2):337-45. PubMed ID: 22700036
[TBL] [Abstract][Full Text] [Related]
8. Lower availability of striatal dopamine transporter in generalized anxiety disorder: a preliminary two-ligand SPECT study.
Lee LT; Tsai HC; Chi MH; Chang WH; Chen KC; Lee IH; Chen PS; Yao WJ; Chiu NT; Yang YK
Int Clin Psychopharmacol; 2015 May; 30(3):175-8. PubMed ID: 25647452
[TBL] [Abstract][Full Text] [Related]
9. Dysregulation of oxytocin and dopamine in the corticostriatal circuitry in bipolar II disorder.
Wei SY; Tseng HH; Chang HH; Lu TH; Chang WH; Chiu NT; Yang YK; Chen PS
Transl Psychiatry; 2020 Aug; 10(1):281. PubMed ID: 32788579
[TBL] [Abstract][Full Text] [Related]
10. Effects of C825T polymorphism of the GNB3 gene on availability of dopamine transporter in healthy volunteers--a SPECT study.
Chen PS; Yeh TL; Lee IH; Lin CB; Tsai HC; Chen KC; Chiu NT; Yao WJ; Yang YK; Chou YH
Neuroimage; 2011 Jun; 56(3):1526-30. PubMed ID: 21371559
[TBL] [Abstract][Full Text] [Related]
11. Dopamine transporter availability in heroin-dependent subjects and controls: longitudinal changes during abstinence and the effects of Jitai tablets treatment.
Liu Y; Han M; Liu X; Deng Y; Li Y; Yuan J; Lv R; Wang Y; Zhang G; Gao J
Psychopharmacology (Berl); 2013 Nov; 230(2):235-44. PubMed ID: 23715641
[TBL] [Abstract][Full Text] [Related]
12. Striatal dopamine transporter availability in unmedicated bipolar disorder.
Anand A; Barkay G; Dzemidzic M; Albrecht D; Karne H; Zheng QH; Hutchins GD; Normandin MD; Yoder KK
Bipolar Disord; 2011 Jun; 13(4):406-13. PubMed ID: 21843280
[TBL] [Abstract][Full Text] [Related]
13. Glucagon-like peptide-1 receptor regulation of basal dopamine transporter activity is species-dependent.
Jensen ME; Galli A; Thomsen M; Jensen KL; Thomsen GK; Klausen MK; Vilsbøll T; Christensen MB; Holst JJ; Owens A; Robertson S; Daws L; Zanella D; Gether U; Knudsen GM; Fink-Jensen A
Neurochem Int; 2020 Sep; 138():104772. PubMed ID: 32464226
[TBL] [Abstract][Full Text] [Related]
14. Availability of dopamine and serotonin transporters in opioid-dependent users--a two-isotope SPECT study.
Yeh TL; Chen KC; Lin SH; Lee IH; Chen PS; Yao WJ; Lee SY; Yang YK; Lu RB; Liao MH; Chiu NT
Psychopharmacology (Berl); 2012 Mar; 220(1):55-64. PubMed ID: 21881874
[TBL] [Abstract][Full Text] [Related]
15. Oxytocin receptor gene rs53576 polymorphism modulates oxytocin-dopamine interaction and neuroticism traits--a SPECT study.
Chang WH; Lee IH; Chen KC; Chi MH; Chiu NT; Yao WJ; Lu RB; Yang YK; Chen PS
Psychoneuroendocrinology; 2014 Sep; 47():212-20. PubMed ID: 25001970
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of the dopamine transporter as an animal model of bipolar disorder mania: Locomotor response, neuroimmunological profile and pharmacological modulation.
Bastos JR; Perico KM; Marciano Vieira ÉL; Teixeira AL; Machado FS; de Miranda AS; Moreira FA
J Psychiatr Res; 2018 Jul; 102():142-149. PubMed ID: 29656188
[TBL] [Abstract][Full Text] [Related]
17. Relationship between SLC6A3 genotype and striatal dopamine transporter availability: a meta-analysis of human single photon emission computed tomography studies.
Costa A; Riedel M; Müller U; Möller HJ; Ettinger U
Synapse; 2011 Oct; 65(10):998-1005. PubMed ID: 21404331
[TBL] [Abstract][Full Text] [Related]
18. Effect of extended-release naltrexone on striatal dopamine transporter availability, depression and anhedonia in heroin-dependent patients.
Zaaijer ER; van Dijk L; de Bruin K; Goudriaan AE; Lammers LA; Koeter MW; van den Brink W; Booij J
Psychopharmacology (Berl); 2015 Jul; 232(14):2597-607. PubMed ID: 25757673
[TBL] [Abstract][Full Text] [Related]
19. Effect of striatal dopamine depletion on cognition in de novo Parkinson's disease.
Chung SJ; Yoo HS; Oh JS; Kim JS; Ye BS; Sohn YH; Lee PH
Parkinsonism Relat Disord; 2018 Jun; 51():43-48. PubMed ID: 29526657
[TBL] [Abstract][Full Text] [Related]
20. Electroconvulsive therapy decreases striatal dopamine transporter binding in patients with depression: A positron emission tomography study with [
Masuoka T; Tateno A; Sakayori T; Tiger M; Kim W; Moriya H; Ueda S; Arakawa R; Okubo Y
Psychiatry Res Neuroimaging; 2020 Jul; 301():111086. PubMed ID: 32464340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
